LONDON – Shell (NYSE: SHEL) will take an impairment charge of up to $2 billion after its Singapore refinery sale and construction suspension of one of Europe’s largest biofuel plants, it said on Friday.
The British energy company announced on Tuesday that it would halt construction at its Rotterdam plant in the Netherlands because of weak market conditions. The biofuels plant was slated to have an annual capacity of 820,000 metric tons a year and begin operations next year.
Shell said the decision will lead to a non-cash, post-tax impairment of between $600 million and $1 billion when it publishes second-quarter results on Aug. 1.
At the same time, Shell expects to take an impairment of $600 to $800 million on the Singapore refining and chemicals hub that it agreed to sell in May.
(Source: ReutersReuters)
Latest News on Shell PLC (SHEL) Stock
Zabih Ullah is a seasoned finance writer with more than ten years of experience. He is highly skilled at analyzing market trends, decoding economic data, and providing insightful commentary on various financial topics. Driven by his curiosity, Zabih stays updated with the latest developments in the finance industry, ensuring that his readers receive timely and relevant news and analysis. Read Full Bio
